Bulgaria Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
103 Pages - SKU: BMI5325537
Countries covered: Bulgaria

Bulgaria Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: The parlous situation of the NHIF and the inability of the Bulgarian parliament to agree on theinterim state budget present considerable risks to our 2014 and 2015 forecasts. Bulgaria's positiveeconomic outlook in 2014/15 will provide a safety buffer, but structural issues within the country'shealthcare system will require legislative reform from the Bulgarian parliament.

Headline Expenditure Projections

Pharmaceuticals: BGN2.32bn (USD1.58bn) in 2013 to BGN2.38bn (USD1.63bn) in 2014; +2.5% inlocal currency terms and 3.2% in US dollar terms. US dollar forecast revised upward due to expectationsof lev appreciation.

More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Bulgaria Prescription Drugs reports

Antibiotics Market in Bulgaria to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Bulgaria. The study provides essential market ...
The Pharmaceutical Market: Bulgaria (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>



    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
US: 800.298.5699
Int'l: +1.240.747.3093

Share this report

    Other tasks

    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!